Everything you need to know about the features and benefits of the Exoskeleton Myosuit from Myoswiss for patients with residual muscle function need to know.
The Myosuit is the ideal movement aid for people with weak legs. It works like an e-bike and provides individual support and strength in the hip area and the legs, always as much as the respective user needs. By using the Myosuit, you can improve your mobility and walk further distances.
The Myosuit is a lightweight, soft and affordable Exoskeleton of the latest generation. It can be used effortlessly in rehabilitation and physiotherapy with patients with pathological muscle weakness and provides additional support and stability in the lower extremities.
The Myosuit is a versatile aid that can be used both in physiotherapy and in everyday activities. The Myosuit makes life easier and can be used both in physiotherapy and in everyday activities.
Yes, with the Myosuit you can also go outside. However, it must be protected from moisture
The Myosuit is handy and lightweight, with a total weight of 5.7 kg.
The surfaces of the Myosuit that come into contact with the body should be cleaned regularly with alcohol-free disinfectant.
The Myosuit is available in one size. Due to the adjustable straps, it can be adapted to a wide range of body sizes in a few simple steps.
Up to 4 hours and then must be recharged. The set includes 2 batteries.
The Myosuit is currently available in Switzerland and Germany.
The Myosuit is a CE-certified medical device and is generally reimbursable and subject to case-by-case review by insurance companies.
The Myosuit is ideal for people with movement restrictions in the legs who want to gain more stability and safety when walking.
This garment is perfect for people who suffer from limited movement in the legs and want to improve their mobility.
It is important that people still have a certain amount of residual muscle function in their legs to be able to use it successfully.
The Myosuit is suitable for people who suffer from pathological muscle weakness in the legs. This can be due to neurological, neuromuscular diseases, due to an accident or age-related weakness.
The exoskeleton is also available as a subscription. MyoSwiss has received a total of $2.5 million in 2 funding rounds. The latest funding was raised in a seed round on July 23, 2020. MyoSwiss is funded by 2 investors. T-Robotics and EASME - EU Executive Agency for SMEs are the latest investors.
Image sources: All images and graphics are copyrighted and property of ©.